Cargando…

Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway

Detalles Bibliográficos
Autores principales:	Rahmat, Muhammad Bakhait, Zhang, Songjing, Koh, Cheng-Gee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791381/ https://www.ncbi.nlm.nih.gov/pubmed/31645909 http://dx.doi.org/10.18632/oncotarget.27255

Ejemplares similares

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

Partners in crime: POPX2 phosphatase and its interacting proteins in cancer
por: Kim, Pu Rum, et al.
Publicado: (2020)

POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
por: Weng, Ting, et al.
Publicado: (2017)

Enhanced Delta-Notch Lateral Inhibition Model Incorporating Intracellular Notch Heterogeneity and Tension-Dependent Rate of Delta-Notch Binding that Reproduces Sprouting Angiogenesis Patterns
por: Koon, Yen Ling, et al.
Publicado: (2018)

Correction: Actin Cytoskeleton Regulates Hippo Signaling
por: Reddy, Pradeep, et al.
Publicado: (2013)

Novel insights into the regulation of LATS2 kinase in prehierarchical follicle development via the Hippo pathway in hen ovary
por: Sun, Xue, et al.
Publicado: (2021)

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
por: Azad, T., et al.
Publicado: (2018)

An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
por: Park, Gun-Soo, et al.
Publicado: (2016)

Correction: LATS1 and LATS2 Phosphorylate CDC26 to Modulate Assembly of the Tetratricopeptide Repeat Subcomplex of APC/C
por: Masuda, Kenta, et al.
Publicado: (2015)

Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis
por: Sarmasti Emami, Sahar, et al.
Publicado: (2020)

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
por: Guo, Chengyong, et al.
Publicado: (2019)

O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
por: Kim, Eunah, et al.
Publicado: (2020)

Correction: Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
Publicado: (2020)

DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma
por: Dong, Qianze, et al.
Publicado: (2017)

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling
por: An, Yang, et al.
Publicado: (2013)

Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
por: Ma, Biao, et al.
Publicado: (2016)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
por: Hergovich, Alexander
Publicado: (2013)

Correction: Salvador–Warts–Hippo pathway regulates sensory organ development via caspase-dependent nonapoptotic signaling
por: Wang, Lan-Hsin, et al.
Publicado: (2019)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner
por: García-Gutiérrez, Lucía, et al.
Publicado: (2022)

Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma
por: Guo, Qingping, et al.
Publicado: (2018)

Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells
por: Li, Lang, et al.
Publicado: (2018)

miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
por: Mohamed, Zeinab, et al.
Publicado: (2018)

Correction: Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT
por: Keller, Baerbel, et al.
Publicado: (2017)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells
por: Luo, Min, et al.
Publicado: (2022)

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
por: Meng, Zhipeng, et al.
Publicado: (2015)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

Correction: LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
por: Han, Qiang, et al.
Publicado: (2021)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020)

Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase–mediated inhibitory phosphorylation of the transcriptional coactivator YAP
por: Thines, Louise, et al.
Publicado: (2022)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j47ce5b0lmf0hvki035gehqf5q